「carcinoma of lung」を含む例文一覧(20)

  • The method is useful in detection of various carcinomas such as hepatocellular carcinoma, carcinoma of the breast, lung carcinoma, gastrointestinal tract carcinoma, genital carcinoma and rib/soft tissue carcinoma, etc.
    上記方法は、肝細胞癌、乳癌、肺癌、胃腸管癌、生殖器癌および骨・軟部組織癌等の種々の癌の検出に有用である。 - 特許庁
  • Further, adenosquamous carcinoma in the lung of male rats and adenosquamous carcinoma together with squamous cell carcinoma in the lung of female rats were identified Further mice were exposed to the same level of concentrations of ITO grinding dusts for 104 weeks, but no cancer identified.
    なお、マウスにも、同様の濃度で104週間ITO研削粉をばく露させたが、発がんは認められなかった。 - 厚生労働省
  • the three main types of non-small cell lung cancer are squamous cell carcinoma, large cell carcinoma, and adenocarcinoma.
    主な非小細胞肺がんとしては、扁平上皮がん、大細胞がん、腺がんの3種類がある。 - PDQ®がん用語辞書 英語版
  • To find out a person having a genetically high onset risk rate of lung adenocarcinoma, lung squamous cell carcinoma and head and neck part carcinoma in an early stage.
    遺伝的に肺腺癌、肺扁平上皮癌および頭頸部癌の発症危険率の高い人を早期に発見すること。 - 特許庁
  • METHOD FOR FORECASTING ONSET RISK RATE OF LUNG CANCER, AND HEAD AND NECK PART CARCINOMA
    肺癌および頭頸部癌の発症危険率を予測する方法 - 特許庁
  • To provide an effective method for detecting, diagnosing, monitoring, staging, precognition, imaging and treating various types of cancers, especially, gynecological cancers such as ovarian cancer, uterine cancer, endometrium cancer and carcinoma of the breast and lung carcinoma.
    様々なタイプの癌、特に特に卵巣癌、子宮癌、子宮内膜癌及び乳癌を含む婦人科系の癌と肺癌を検出、診断、監視、段階づけ、予知、造影及び治療するために効果的な方法を提供する。 - 特許庁
  • This method can forecast the onset risk rate of the lung adenocarcinoma, lung squamous cell carcinoma and head and neck part carcinoma of a subject by examining a mis-sense one base polymorphism in at least one gene among hRAD17 gene, POLD1 gene, RASSF1 gene, ETL1 gene, DUSP6 gene, hEXOI gene and WRN gene on the chromosomes of the subject and analyzing.
    被験者の染色体上の、hRAD17遺伝子、POLD1遺伝子、RASSF1遺伝子、ETL1遺伝子、DUSP6遺伝子、hEXOI遺伝子およびWRN遺伝子のうちの少なくとも１つの遺伝子におけるミスセンス１塩基多型を調べ、その遺伝子型を解析することにより、被験者が肺腺癌、肺扁平上皮癌および頭頸部癌をそれぞれ発症する危険率を予測することができる。 - 特許庁
  • In another aspect, the product is used in the treatment of various types of cancer such as leukemia, colorectal cancer, lung cancer, breast cancer, liver cancer, nasopharyngeal carcinoma and esophageal cancer.
    もう一つの側面において、当該製品は白血病、大腸癌、肺癌、乳癌、肝臓癌、上咽頭癌、および食道癌のような種々の癌の治療に使用される。 - 特許庁
  • The antibodies and fragments thereof may be used in the treatment of tumors that express elevated levels of IGF-I receptor, such as breast cancer, colon cancer, lung cancer, ovarian carcinoma, synovial sarcoma, prostate cancer, and pancreatic cancer.
    上記抗体およびそのフラグメントを利用した、増加したIGF-I受容体を発現する腫瘍、例えば乳癌、大腸癌、肺癌、前立腺癌、卵巣癌、滑膜癌、骨肉腫および膵癌の治療。 - 特許庁
  • The methods may be used to treat several different types of cancers and papillomas, including colon carcinoma, prostate cancer, breast cancer, lung cancer, melanoma, hepatoma, brain lymphoma and head and neck cancer.
    本発明による方法は、結腸悪性腫瘍、前立腺癌、乳癌、肺癌、黒色腫、ヘパトーマ、脳リンフォーマ、および頭部と首の癌を含む種々の異なったタイプの癌および乳頭腫の治療に用いることができる。 - 特許庁
  • The compound is useful for treatment of cancers which cancers are carcinoma (such as lung cancer, pancreatic cancer, thyroid cancer, urinary bladder cancer or colonic cancer), bone marrow carcinosis (such as myelogenic leukemia) and adenoma (such as choriocarcinoma).
    本発明の化合物は、癌の治療に有用であり、これらの癌には、癌腫（例えば、肺癌、膵臓癌、甲状腺癌、膀胱癌または結腸癌）、骨髄疾患（例えば、骨髄性白血病）および腺腫（例えば、絨毛結腸腺腫）が挙げられる。 - 特許庁
  • This non-recurrent survival period-extending agent after the excision of lung squamous cell carcinoma in the IB stage according to the histopathological stage classification is provided by incorporating an aminopeptidase inhibitor as an active ingredient.
    アミノペプチダーゼ阻害剤を有効成分とする、病理組織学的病期分類Ｉ期の肺扁平上皮癌における無再発生存期間延長剤。 - 特許庁
  • This supplemental immunotherapeutic agent after the excision of lung squamous cell carcinoma in the IB stage according to the histopathological stage classification is provided by incorporating an aminopeptidase inhibitor as an active ingredient.
    アミノペプチダーゼ阻害剤を有効成分とする、病理組織学的病期分類ＩＢ期の肺扁平上皮癌切除手術後の補助免疫療法剤。 - 特許庁
  • And, thereby, the composition is useful for treatment of all solid carcinomas and lymphomas and especially useful for tumors such as cutaneous cancer, urinary bladder cancer, mastocarcinoma, uterine cancer, ovarian cancer, prostatic cancer, lung cancer, colon cancer, pancreatic cancer, renal carcinoma and stomach cancer.
    従って、全ての固形癌及びリンパ腫、特には、皮膚癌、膀胱癌、乳癌、子宮癌、卵巣癌、前立腺癌、肺癌、大腸癌、膵癌、腎癌、胃癌などの腫瘍の治療に有用である。 - 特許庁
  • The invention relates to the RNAi sequences useful as therapeutics in the treatment of cancers of various types, including prostate cancer, sarcomas such as osteosarcoma, renal cell carcinoma, breast cancer, bladder cancer, lung cancer, colon cancer, ovarian cancer, anaplastic large cell lymphoma and melanoma, and Alzheimer's disease.
    前立腺癌、骨肉腫などの肉腫、腎細胞癌、乳癌、膀胱癌、肺癌、結腸癌、卵巣癌、未分化大細胞リンパ腫及びメラノーマを含む様々な種類の癌の治療、及びアルツハイマー病の治療における治療薬として有用であるＲＮＡｉ配列。 - 特許庁
  • The RNAi sequences are useful as therapeutics in the treatment of cancers of various types, including prostate cancer, sarcomas such as osteosarcoma, renal cell carcinoma, breast cancer, bladder cancer, lung cancer, colon cancer, ovarian cancer, undifferentiated large cell lymphoma and melanoma, and Alzheimer's disease.
    前立腺癌、骨肉腫などの肉腫、腎細胞癌、乳癌、膀胱癌、肺癌、結腸癌、卵巣癌、未分化大細胞リンパ腫及びメラノーマを含む様々な種類の癌の治療、及びアルツハイマー病の治療における治療薬として有用であるＲＮＡｉ配列。 - 特許庁
  • An excellent therapeutic effect can be achieved on non-small cell lung carcinoma which is in such a state that no effective therapeutic method is established for a progressive cancer which is not operable and is one of cancers where chemotherapy is most difficult to apply.
    外科手術ができなくて、化学療法が最も難しい癌の一つである進行癌については未だ有効な治療方法が確立されていないと言わざるを得ない現状にある非小細胞肺癌に対して優れた治療効果を得ることができる。 - 特許庁
  • To provide a method for detecting and locating lung cancer, adrenal cancer, melanoma, colon cancer, colorectal cancer, ovarian cancer, prostate cancer, liver cancer, subcutaneous cancer, intestinal cancer, hepatocellular carcinoma, retinoblastoma, cervical cancer in subject that has or is suspected of having cancer in one embodiment.
    本発明は、ある態様において、癌である又はその疑いのある患者において、肺癌、副腎癌、黒色腫、結腸癌、結腸直腸癌、卵巣癌、前立腺癌、肝臓癌、皮下癌、腸癌、肝細胞癌、網膜芽腫、子宮けい癌を検出し、かつ、部位を特定する方法を提供する。 - 特許庁
  • To provide usage of RNAi sequences as therapeutics in the treatment of cancers of various types, including prostate cancer, sarcomas such as osteosarcoma, renal cell carcinoma, breast cancer, bladder cancer, lung cancer, colon cancer, ovarian cancer, undifferentiated large cell lymphoma and melanoma, and Alzheimer's disease, and a method for treating these diseases by administration of RNA molecules having RNAi activity to those individual including human individual in need of these treatment.
    本発明は、前立腺癌、骨肉腫などの肉腫、腎細胞癌、乳癌、膀胱癌、肺癌、結腸癌、卵巣癌、未分化大細胞リンパ腫及びメラノーマを含む様々な種類の癌の治療及びアルツハイマー病の治療におけるＲＮＡｉ配列の使用、並びにＲＮＡｉ活性を有するＲＮＡ分子を、これらの治療を必要とするヒト個体を含む個体に投与することによる、これらの病気を治療する方法を提供する。 - 特許庁
  • To provide a method for using RNAi sequences in the treatment of cancers of various types, including prostate cancer, sarcomas such as osteosarcoma, renal cell carcinoma, breast cancer, bladder cancer, lung cancer, colon cancer, ovarian cancer, anaplastic large cell lymphoma and melanoma, and Alzheimer's disease, and to provide a method for treating individual, including human individual in need of such treatment by administering an RNA molecule having RNAi activity.
    本発明は前立腺癌、骨肉腫などの肉腫、腎細胞癌、乳癌、膀胱癌、肺癌、結腸癌、卵巣癌、未分化大細胞リンパ腫及びメラノーマを含む様々な種類の癌の治療及びアルツハイマー病の治療におけるこれらのＲＮＡｉ配列の使用、並びにＲＮＡｉ活性を有するＲＮＡ分子を、これらの治療を必要とするヒト個体を含む個体に投与することによる、これらの病気を治療する方法を提供する。 - 特許庁

例文データの著作権について